AnaptysBio, Inc.ANABNASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending lower, below historical average, strong compound growth.
Left:
|
|
|
|

Operating cash flow minus capital expenditures

Latest
$-135.69M
↓ 146% below average
Average (9y)
$-55.19M
Historical baseline
Range
High:$-9.08M
Low:$-135.69M
CAGR
+33.7%
Consistent expansion
PeriodValueChange
2024$-135.69M-11.6%
2023$-121.61M-64.4%
2022$-73.95M-56.4%
2021$-47.29M-221.1%
2020$-14.73M+79.1%
2019$-70.32M-41.9%
2018$-49.57M-151.3%
2017$-19.73M-117.3%
2016$-9.08M+8.3%
2015$-9.91M-